Le N, Pham Y, Le C, Le L, Le T, Dao H
Sci Rep. 2024; 14(1):21378.
PMID: 39271688
PMC: 11399399.
DOI: 10.1038/s41598-024-66553-5.
Jafari S, Lajevardi Z, Zamani Fard M, Jafari A, Naghavi S, Ravaei F
Cell Biochem Biophys. 2024; 82(4):3123-3144.
PMID: 39026059
DOI: 10.1007/s12013-024-01437-z.
Kim B, Jung J
Biomedicines. 2024; 12(4).
PMID: 38672219
PMC: 11048406.
DOI: 10.3390/biomedicines12040865.
Giansante V, Stati G, Sancilio S, Guerra E, Alberti S, Di Pietro R
Int J Mol Sci. 2023; 24(16).
PMID: 37628814
PMC: 10454309.
DOI: 10.3390/ijms241612633.
Liu T, Joshu C, Lu J, Prizment A, Chatterjee N, Coresh J
Int J Cancer. 2023; 153(6):1201-1216.
PMID: 37338014
PMC: 11178147.
DOI: 10.1002/ijc.34624.
Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic Adenocarcinoma.
Firpo M, Boucher K, Bleicher J, Khanderao G, Rosati A, Poruk K
JCO Clin Cancer Inform. 2023; 7:e2200160.
PMID: 36913644
PMC: 10530881.
DOI: 10.1200/CCI.22.00160.
Prognostic implications of microRNA-21 overexpression in pancreatic ductal adenocarcinoma: an international multicenter study of 686 patients.
Ali A, Jamieson N, Khan I, Chang D, Giovannetti E, Funel N
Am J Cancer Res. 2023; 12(12):5668-5683.
PMID: 36628279
PMC: 9827095.
Case Report: Anlotinib combined with PD-1 inhibitor and sequential GA regimen or FOLFIRINOX Chemotherapy in treatment of KRAS G12V mutated pancreatic ductal adenocarcinoma with liver metastasis: A case and literature review.
Wang Y, Wang B, Xiang L, Deng J, Xu B, He P
Front Immunol. 2022; 13:1016647.
PMID: 36311715
PMC: 9606775.
DOI: 10.3389/fimmu.2022.1016647.
Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma.
Li Q, Hu Y, Chen L, Schnaubelt M, Zhou D, Li Y
Clin Proteomics. 2022; 19(1):36.
PMID: 36266629
PMC: 9583468.
DOI: 10.1186/s12014-022-09373-x.
Monomerization of Homodimeric Trefoil Factor 3 (TFF3) by an Aminonitrile Compound Inhibits TFF3-Dependent Cancer Cell Survival.
Pandey V, Zhang X, Poh H, Wang B, Dukanya D, Ma L
ACS Pharmacol Transl Sci. 2022; 5(9):761-773.
PMID: 36110371
PMC: 9469493.
DOI: 10.1021/acsptsci.2c00044.
Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAIL.
Moser R, Annis J, Nikolova O, Whatcott C, Gurley K, Mendez E
Cancer Res. 2022; 82(18):3375-3393.
PMID: 35819261
PMC: 9481717.
DOI: 10.1158/0008-5472.CAN-21-4222.
Characterization of core fucosylation via sequential enzymatic treatments of intact glycopeptides and mass spectrometry analysis.
Cao L, Lih T, Hu Y, Schnaubelt M, Chen S, Zhou Y
Nat Commun. 2022; 13(1):3910.
PMID: 35798744
PMC: 9262967.
DOI: 10.1038/s41467-022-31472-4.
An Inflammatory Response-Related Gene Signature Reveals Distinct Survival Outcome and Tumor Microenvironment Characterization in Pancreatic Cancer.
Xie F, Huang X, He C, Wang R, Li S
Front Mol Biosci. 2022; 9:876607.
PMID: 35755810
PMC: 9216734.
DOI: 10.3389/fmolb.2022.876607.
Circulating proteins and risk of pancreatic cancer: a case-subcohort study among Chinese adults.
Kartsonaki C, Pang Y, Millwood I, Yang L, Guo Y, Walters R
Int J Epidemiol. 2022; 51(3):817-829.
PMID: 35064782
PMC: 9189974.
DOI: 10.1093/ije/dyab274.
The next "sweet" spot for pancreatic ductal adenocarcinoma: Glycoprotein for early detection.
Xu Y, Wang Y, Hoti N, Clark D, Chen S, Zhang H
Mass Spectrom Rev. 2021; 42(2):822-843.
PMID: 34766650
PMC: 9095761.
DOI: 10.1002/mas.21748.
Infection Masquerading as Recurrence of Pancreatic Ductal Adenocarcinoma: A Cautionary Tale.
Arivazhagan S, Kantamani D, Tanner N, Kundranda M, Stagg M
Cureus. 2021; 13(8):e17010.
PMID: 34540411
PMC: 8424059.
DOI: 10.7759/cureus.17010.
Proteogenomic characterization of pancreatic ductal adenocarcinoma.
Cao L, Huang C, Zhou D, Hu Y, Lih T, Savage S
Cell. 2021; 184(19):5031-5052.e26.
PMID: 34534465
PMC: 8654574.
DOI: 10.1016/j.cell.2021.08.023.
Post-pancreatitis diabetes mellitus and excess intra-pancreatic fat deposition as harbingers of pancreatic cancer.
Petrov M
World J Gastroenterol. 2021; 27(17):1936-1942.
PMID: 34007131
PMC: 8108030.
DOI: 10.3748/wjg.v27.i17.1936.
Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
Hanna-Sawires R, Schiphuis J, Wuhrer M, Vasen H, van Leerdam M, Bonsing B
Int J Mol Sci. 2021; 22(5).
PMID: 33800786
PMC: 7961509.
DOI: 10.3390/ijms22052655.
Diagnostic model for pancreatic cancer using a multi-biomarker panel.
Choi Y, Yoon W, Lee A, Han Y, Byun Y, Kang J
Ann Surg Treat Res. 2021; 100(3):144-153.
PMID: 33748028
PMC: 7943279.
DOI: 10.4174/astr.2021.100.3.144.